Chapter 49. Chapter 49. Bisphosphonates for Postmenopausal Osteoporosis

  1. ASBMR
  1. Socrates E. Papapoulos

Published Online: 23 DEC 2009

DOI: 10.1002/9780470623992.ch49

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism

How to Cite

ASBMR (2008) Chapter 49. Bisphosphonates for Postmenopausal Osteoporosis, in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470623992.ch49

Publication History

  1. Published Online: 23 DEC 2009
  2. Published Print: 18 NOV 2008

ISBN Information

Print ISBN: 9780977888214

Online ISBN: 9780470623992

SEARCH

Keywords:

  • bisphosphonates;
  • alendronate;
  • clodronate;
  • ibandronate;
  • pamidronate;
  • risedronate;
  • zoledronate;
  • vertebral fractures;
  • nonvertebral fractures

Summary

This chapter contains sections titled:

  • Introduction

  • Pharmacology

  • Antifracture Efficacy

  • Intermittent Administration of BPs

  • Long-Term Effects on Bone Fragility

  • Special Issues Related to Treatment of Osteoporosis with BPs

  • Adverse Effects

  • General Conclusions